COVID-19 is expected to adapt consumer shopping habits in 2020, following the trends seen in the wider OTC landscape. As such, paediatric acetaminophen is set to record heightened growth for the year, with consumers preferencing the pain killer above alternatives, driven by stories surrounding the adverse effects that ibuprofen may have on those suffering from COVID-19. As such, whereas growth in paediatric acetaminophen will improve, paediatric ibuprofen is set to record a sharp value decline.
The Paediatric Consumer Health in Norway report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2015-2019, allowing you to identify the sectors driving growth. Forecasts to 2024 illustrate how the market is set to change.
Product coverage: Nappy (Diaper) Rash Treatments, Paediatric Analgesics, Paediatric Cough, Cold and Allergy Remedies, Paediatric Dermatologicals, Paediatric Digestive Remedies, Paediatric Vitamins and Dietary Supplements.
Data coverage: Market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
The Paediatric Consumer Health in Norway report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2015-2019, allowing you to identify the sectors driving growth. Forecasts to 2024 illustrate how the market is set to change.
Product coverage: Nappy (Diaper) Rash Treatments, Paediatric Analgesics, Paediatric Cough, Cold and Allergy Remedies, Paediatric Dermatologicals, Paediatric Digestive Remedies, Paediatric Vitamins and Dietary Supplements.
Data coverage: Market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the Paediatric Consumer Health market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
Note: Product cover images may vary from those shown
KEY DATA FINDINGS
2020 IMPACT
GLOBAL INDUSTRY ENVIRONMENT
DISCLAIMER
DEFINITIONS
SOURCES
2020 IMPACT
- Paediatric acetaminophen performs well, while negative press leads to a decline in sales for paediatric ibuprofen
- Although Rx medications remain an ongoing threat, due to the COVID-19 virus, paediatric cough, cold and allergy remedies record double-digit value growth
- Orkla Health AS retains its lead while Karo Pharma benefits from increased interest in paediatrics analgesics, boosting sales of Paracet
- Growth to be steady across the forecast period, albeit, lower than 2020, as demand for acetaminophen returns to normal
- Nappy (diaper) rash treatments and paediatric cough/cold remedies benefit from children in Norway suffering from a high level of eczema and coughs and colds
- Players compete through packaging and designs, while retailers make more space for paediatric consumer health products, boosting sales
- Table 1 Sales of Paediatric Consumer Health by Category: Value 2015-2020
- Table 2 Sales of Paediatric Consumer Health by Category: % Value Growth 2015-2020
- Table 3 Sales of Paediatric Vitamins and Dietary Supplements by Type: % Value 2015-2020
- Table 4 NBO Company Shares of Paediatric Consumer Health: % Value 2016-2020
- Table 5 LBN Brand Shares of Paediatric Consumer Health: % Value 2017-2020
- Table 6 Forecast Sales of Paediatric Consumer Health by Category: Value 2020-2025
- Table 7 Forecast Sales of Paediatric Consumer Health by Category: % Value Growth 2020-2025
- COVID-19 impact on consumer health
- COVID-19 country impact
- Company response
- Retailing shift
- What next for consumer health?
- Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2015-2020
- Table 9 Life Expectancy at Birth 2015-2020
- Table 10 Sales of Consumer Health by Category: Value 2015-2020
- Table 11 Sales of Consumer Health by Category: % Value Growth 2015-2020
- Table 12 NBO Company Shares of Consumer Health: % Value 2016-2020
- Table 13 LBN Brand Shares of Consumer Health: % Value 2017-2020
- Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2015-2020
- Table 15 Distribution of Consumer Health by Format: % Value 2015-2020
- Table 16 Distribution of Consumer Health by Format and Category: % Value 2020
- Table 17 Forecast Sales of Consumer Health by Category: Value 2020-2025
- Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2020-2025
- OTC registration and classification
- Vitamins and dietary supplements registration and classification
- Self-medication/self-care and preventive medicine
- Switches
- Summary 1 OTC: Switches 2019-2020
GLOBAL INDUSTRY ENVIRONMENT
DISCLAIMER
DEFINITIONS
SOURCES
- Summary 2 Research Sources
Note: Product cover images may vary from those shown
